News about "Mankind Pharma "

Mankind Pharma Acquires Rivotril Brand for India, Reinforcing Focus on Chronic CNS Therapies

Mankind Pharma Limited today announced that it has acquired the brand Rivotril from Roche for the Indian market, with exclusive rights to manufacture, market and distribute the product across the country. Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions.

Mankind Pharma | 19/03/2026 | By Darshana

Mankind Pharma Urges Greater Kidney Health Awareness as CKD Burden Rises

On World Kidney Day, Mankind Pharma highlights rising cases of Chronic Kidney Disease in India and stresses early screening, lifestyle changes and awareness to prevent late-stage diagnosis.

Mankind Pharma | 12/03/2026 | By News Bureau

Mankind Pharma Sees Margin Expansion, Chronic Segment Gains in Q3FY26

Mankind Pharma announced its consolidated financial results for the third quarter and nine months ended December 31, 2025, reporting steady growth driven by improved performance in its domestic pharmaceutical business and consolidation of its BSV portfolio.

Mankind Pharma | 04/02/2026 | By Darshana |  136

Actimed Therapeutics Announces Licensing Agreement with Mankind Pharma

Actimed Therapeutics has entered into an exclusive licensing agreement with Mankind Pharma for S-pindolol, its novel therapy in development for cancer cachexia. The partnership marks a step toward delivering the first globally approved treatment for this debilitating condition to patients across India and South Asia.

Mankind Pharma | 21/11/2025 | By Dineshwori |  118

Mankind Pharma Q2 Net Profit Falls 21 Percent to INR 520 Crore

Mankind Pharma reported a 21 percent year-on-year decline in consolidated net profit for the quarter ended September 30, 2025, with profit falling to approximately INR 520 crore from INR 661 crore in the same period last year.

Mankind Pharma | 07/11/2025 | By Darshana |  200

Mankind Pharma Partners with OpenAI to Embed AI Across Operations

Mankind Pharma has announced a strategic collaboration with OpenAI, aimed at integrating artificial intelligence across its entire value chain. The move marks one of the first times an Indian pharmaceutical company has committed to fully embedding advanced AI into its core operations.

Mankind Pharma | 18/09/2025 | By Darshana |  465

Mankind Pharma Gets CDSCO Nod to Begin Phase 1 Trials of Novel Autoimmune Drug Candidate MKP11093

Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor.

Mankind Pharma | 08/09/2025 | By Darshana |  159

Mankind Pharma Expands into Sri Lanka With New Subsidiary

Mankind Pharma has incorporated a wholly owned subsidiary, Mankind Pharma Lanka (Private) Ltd., in Sri Lanka as part of its international expansion strategy.

Mankind Pharma | 26/07/2025 | By Dineshwori |  310

Mankind Pharma, Innovent Biologics to Commercialize Sintilimab for Cancer Care

This strategic collaboration aims to address the critical challenges in cancer treatment and improve patient access to innovative therapeutic options in the region.

Mankind Pharma | 27/12/2024 | By Aishwarya |  380

Mankind Pharma Bags CCI Approval for BSV Acquisition

The proposed transaction involves the acquisition of 100 percent shareholding of Bharat Serums and Vaccines Ltd. (BSV) by Mankind Pharma Ltd.

Mankind Pharma | 10/10/2024 | By Aishwarya |  645